Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NTRB is expected to report earnings to fall 88.00% to -5 cents per share on June 28
Q2'23
Est.
$-0.06
Q1'25
Missed
by $0.38
Q1'23
Missed
by $0.17
Q4'22
Missed
by $0.03
Q3'22
Est.
$-0.12
The last earnings report on May 02 showed earnings per share of -50 cents, missing the estimate of -11 cents. With 32.13K shares outstanding, the current market capitalization sits at 79.58M.